[Pathophysiologic and therapeutic significance of cyclic nucleotides].
D000700:Analgesics; D000818:Animals; D000893:Anti-Inflammatory Agents; D000970:Antineoplastic Agents; D001011:Aorta / Q000032:analysis; D001161:Arteriosclerosis / Q000378:metabolism; D003994:Bucladesine / Q000494:pharmacology / Q000627:therapeutic use; D002454:Cell Differentiation / Q000187:drug effects; D000242:Cyclic AMP / Q000032:analysis; D003920:Diabetes Mellitus / Q000378:metabolism; D003995:Dibutyryl Cyclic GMP / Q000627:therapeutic use; D004723:Endorphins / Q000627:therapeutic use; D006801:Humans; D006961:Hyperparathyroidism / Q000378:metabolism; D006973:Hypertension / Q000378:metabolism; D007011:Hypoparathyroidism / Q000378:metabolism; D008099:Liver / Q000187:drug effects; D051379:Mice; D008938:Mitosis / Q000187:drug effects; D009020:Morphine / Q000627:therapeutic use; D009712:Nucleotides, Cyclic / Q000627:therapeutic use*; D011547:Pseudohypoparathyroidism / Q000378:metabolism; D051381:Rats; D012769:Shock / Q000188:drug therapy
D000700:Analgesics; D000893:Anti-Inflammatory Agents; D000970:Antineoplastic Agents; D004723:Endorphins; D009712:Nucleotides, Cyclic; D003995:Dibutyryl Cyclic GMP; D003994:Bucladesine; D009020:Morphine; D000242:Cyclic AMP
Patofiziologicheskoe i terapevticheskoe znachenie tsiklicheskikh nukleotidov.